Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CLK1 | P49759 | 20/20 | 0.59 |
| ▸ | CLK4 | Q9HAZ1 | 19/20 | 0.59 |
| ▸ | DYRK1A | Q13627 | 18/20 | 0.59 |
| ▸ | DYRK2 | Q92630 | 18/20 | 0.59 |
| ▸ | DYRK1B | Q9Y463 | 18/20 | 0.59 |
| ▸ | CLK2 | P49760 | 18/20 | 0.59 |
| ▸ | DYRK3 | O43781 | 17/20 | 0.59 |
| ▸ | CLK3 | P49761 | 15/20 | 0.59 |
| ▸ | DYRK4 | Q9NR20 | 14/20 | 0.59 |
| ▸ | GSK3B | P49841 | 11/20 | 0.59 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.55 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.55 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.48 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.48 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28842957 | 1.00 | CLK1 (0.59) | CLK1CLK4DYRK1ADYRK2DYRK1B | |
| SCHEMBL29899977 | 1.00 | CLK1 (0.59) | CLK1CLK4DYRK1ADYRK2DYRK1B | |
| SCHEMBL28953208 | 0.95 | CLK1 (0.58) | CLK1CLK4DYRK1ADYRK2DYRK1B | |
| SCHEMBL29899856 | 0.95 | CLK1 (0.58) | CLK1CLK4DYRK1ADYRK2DYRK1B | |
| SCHEMBL28953207 | 0.95 | CLK1 (0.58) | CLK1CLK4DYRK1ADYRK2DYRK1B | |
| SCHEMBL29899822 | 0.87 | CLK1 (0.60) | CLK1CLK4DYRK1ADYRK2DYRK1B | |
| SCHEMBL23510736 | 0.87 | CLK1 (0.60) | CLK1CLK4DYRK1ADYRK2DYRK1B | |
| SCHEMBL28842989 | 0.87 | CLK1 (0.60) | CLK1CLK4DYRK1ADYRK2DYRK1B | |
| SCHEMBL23510632 | 0.85 | CLK1 (0.62) | CLK1CLK4DYRK1ADYRK2DYRK1B | |
| SCHEMBL29899840 | 0.85 | CLK1 (0.62) | CLK1CLK4DYRK1ADYRK2DYRK1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114929690-B | Novel heterocyclic derivatives having cardiomyocyte proliferative activity for the treatment of heart disease | 同济大学 | 2023-05-05 | — | — | CN | disclosed |
| US-20230025301-A1 | Novel Heterocyclic Derivatives with Cardiomyocyte Proliferation Activity for Treatment of Heart Diseases | TONGJI UNIVERSITY (CN) | 2023-01-26 | — | — | US | disclosed |
| CN-114929690-A | Novel heterocyclic derivatives with cardiomyocyte proliferative activity for the treatment of cardiac diseases | 同济大学 | 2022-08-19 | — | — | CN | disclosed |
| WO-2021115489-A1 | NOVEL HETEROCYCLIC DERIVATIVES WITH CARDIOMYOCYTE PROLIFERATION ACTIVITY FOR TREATMENT OF HEART DISEASES | TONGJI UNIVERSITY (CN) | 2021-06-17 | — | — | WO | disclosed |
| WO-2021114314-A1 | NOVEL HETEROCYCLIC DERIVATIVES WITH CARDIOMYOCYTE PROLIFERATION ACTIVITY FOR TREATMENT OF HEART DISEASES | TONGJI UNIVERSITY (CN) | 2021-06-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230025301-A1 | Novel Heterocyclic Derivatives with Cardiomyocyte Proliferation Activity for Treatment of Heart Diseases | TNNI3, TNNT2, MKI67 | CLK1 2884/4885CLK4 1817/4885DYRK1A 3319/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.